Andlauer Healthcare Group (AND) Stock Price, News & Analysis

Company Overview

Andlauer Healthcare Group Inc is an investment holding company. It operates in two segments namely Specialized Transportation and Healthcare Logistics. The company generates maximum revenue from the Specialized Transportation segment. Its Specialized Transportation segment provides specialized temperature controlled services to healthcare customers. The company's transportation products include ground transportation, air freight forwarding, and dedicated and last mile delivery. The Healthcare Logistics segment provides contract logistics services for customers, including logistics and distribution, and packaging.

Key Stats

• Today's Range: C$53.26 to C$53.42
• 50-Day Range: C$52.20 to C$53.60
• 52-Week Range: C$36.68 to C$53.93
• Volume: 25,213 shs
• Average Volume: 70,394 shs
• Market Capitalization: C$2.09 billion
• P/E Ratio: 31.41
• Dividend Yield: 0.86%
• Price Target: C$52.75
• Consensus Rating: Reduce

Andlauer Healthcare Group Stock Analysis - MarketRank™

Andlauer Healthcare Group scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.8 / 5
• Analyst Rating: Reduce

Consensus Rating

Andlauer Healthcare Group has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no buy ratings, 2 hold ratings, and 1 sell rating.

Upside/Downside

The consensus price target for Andlauer Healthcare Group is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Andlauer Healthcare Group has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Andlauer Healthcare Group is 31.41, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 277.77.

Price to Earnings Ratio vs. Sector

The P/E ratio of Andlauer Healthcare Group is 31.41, which means that it is trading at a less expensive P/E ratio than the Industrials sector average P/E ratio of about 312.79.

Price to Book Value per Share Ratio

Andlauer Healthcare Group has a P/B Ratio of 5.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for AND.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Andlauer Healthcare Group has a dividend yield of 0.86%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Andlauer Healthcare Group does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Andlauer Healthcare Group is 27.06%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for AND.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

Search Interest

Only 22 people have searched for AND on MarketBeat in the last 30 days. This is a decrease of -27% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Andlauer Healthcare Group insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.81% of the stock of Andlauer Healthcare Group is held by insiders.

Percentage Held by Institutions

Only 25.68% of the stock of Andlauer Healthcare Group is held by institutions.

AND Stock Analysis - Frequently Asked Questions

How have AND shares performed this year?

Andlauer Healthcare Group's stock was trading at C$42.20 at the start of the year. Since then, AND stock has increased by 26.5% and is now trading at C$53.39.

How were Andlauer Healthcare Group's earnings last quarter?

Andlauer Healthcare Group Inc. (TSE:AND) announced its quarterly earnings data on Tuesday, November, 5th. The company reported $0.41 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.44 by $0.03. Andlauer Healthcare Group had a net margin of 10.06% and a trailing twelve-month return on equity of 14.90%.
Read the conference call transcript.

How do I buy shares of Andlauer Healthcare Group?

Shares of AND stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Andlauer Healthcare Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Andlauer Healthcare Group investors own include MTY Food Group (MTY), Arista Networks (ANET), NVIDIA (NVDA), Crown Castle (CCI), Taiwan Semiconductor Manufacturing (TSM), Enbridge (ENB) and Innovative Industrial Properties (IIPR).

Company Calendar

• Last Earnings: 11/05/2024
• Record date for 7/15 Dividend: 6/30/2025
• Dividend Payable: 7/15/2025
• Today: 9/05/2025

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Industrials
• Industry: Integrated Freight & Logistics
• Sub-Industry: N/A
• Current Symbol: TSE:AND
• CIK: N/A
• Web: www.andlauerhealthcare.com
• Phone: 416 744 4900
• Fax: N/A
• Employees: 2,290
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Andlauer Healthcare Group: C$52.75
• High Price Target: C$55.00
• Low Price Target: C$49.00
• Potential Upside/Downside: -1.1%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): C$1.70
• Trailing P/E Ratio: 31.36
• Forward P/E Ratio: 27.58
• P/E Growth: N/A
• Net Income: C$66.28 million
• Net Margins: 10.06%
• Pretax Margin: N/A
• Return on Equity: 14.90%
• Return on Assets: 8.52%

Debt

• Debt-to-Equity Ratio: 39.31
• Current Ratio: 1.44
• Quick Ratio: 1.66

Sales & Book Value

• Annual Sales: C$650.58 million
• Price / Sales: 3.21
• Cash Flow: C$1.33 per share
• Price / Cash Flow: 40.15
• Book Value: C$10.27 per share
• Price / Book: 5.19

Miscellaneous

• Outstanding Shares: 39,150,000
• Free Float: N/A
• Market Cap: C$2.09 billion
• Optionable: Not Optionable
• Beta: 0.72